Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat c6 glioma cells
J.M. Elliott(University of Oxford), R.A. Leslie(Unknown), Nigel R. Newberry(University of Oxford), A. David Smith(Emory University), A.C. Reavley(University of Oxford), Mark A. Wigmore(University of Oxford), Christopher W. Smith(University of Oxford), Rebecca Newton(University of Manchester), J.T. Bartrup(University of Oxford), Stephen J. Briddon(University of Nottingham), Thomas P. Flanigan(University of Oxford), J.E. Carey(University of Oxford), S. L. Phipps(University of Oxford), A. Cholewinski(University of Oxford)
Cited by 27
Related Papers
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
|Clinical Chemistry|2004|1.1k
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
|PLoS ONE|2010|614
Homocysteine and Dementia: An International Consensus Statement
|Journal of Alzheimer s Disease|2018|360